Evidence map›Paper›PMID 40107464›Full record

ArticleJournal of pain and symptom management2025

The Effect of Race and Area Deprivation on Symptom Profiles Over the Course of Early-Stage Breast Cancer.

Hiba Abujaradeh, Julia O'Brien, Susan R Mazanec, Catherine M Bender, Isabelle M Schlemmer, Adam M Brufsky, Elham Nasrollahi, Margaret Rosenzweig

Abstract read
In one paragraph

Article in Journal of pain and symptom management, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Factors influencing patient-reported symptom outcomes in women with metastatic breast cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Hiba AbujaradehUniversity of Pittsburgh School of Nursing, Pittsburgh, PA, USA (H.A., J.O.B., C.M.B., I.M.S.).
Julia O'BrienUniversity of Pittsburgh School of Nursing, Pittsburgh, PA, USA (H.A., J.O.B., C.M.B., I.M.S.).
Susan R MazanecCase Western University Frances Payne Bolton School of Nursing, Cleveland, OH, USA (S.R.M.).
Catherine M BenderUniversity of Pittsburgh School of Nursing, Pittsburgh, PA, USA (H.A., J.O.B., C.M.B., I.M.S.).
Isabelle M SchlemmerUniversity of Pittsburgh School of Nursing, Pittsburgh, PA, USA (H.A., J.O.B., C.M.B., I.M.S.).
Adam M BrufskyUniversity of Pittsburgh Medical Center UPMC Hillman Cancer, Pittsburgh, PA, USA (A.M.B.).
Elham NasrollahiUPMC Pinnacle, Harrisnurgh, PA, USA (E.N.).
Margaret RosenzweigUniversity of Pittsburgh School of Nursing, Pittsburgh, PA, USA (H.A., J.O.B., C.M.B., I.M.S.). Electronic address: mros@pitt.edu.

Funding

The Symptom Experience, Management and Outcomes According to Race and Social Determinants of Health (SEMOARS) during Breast Cancer ChemotherapyR01MD012245 · NIMHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROSENZWEIG, MARGARET Q. · 2017 to 2021
$3.3M
NIMHD NIH HHS R01 MD012245
6 · The paper itself

Abstract

contextLimited research has examined racial disparities in symptom burden prior to chemotherapy initiation, during and at the chemotherapy completion.

objectiveTo describe and compare the symptom burden (fatigue, pain, and physical functioning) and change over time between Black and White women receiving Early-Stage Breast Cancer (ESBC) chemotherapy while considering social determinants of health.

methodsA longitudinal, repeated measures comparative design was employed. Time points of symptom measurement (PROMIS domains) at baseline, mid and end point were adjusted as per patient chemotherapy schedule. Linear mixed models were applied.

resultsThere were 149 patients, 36% Black 64% White (54 ± 12 years) recommended to receive ESBC chemotherapy with adequate data for symptom analysis. PAIN: Main effect of race was significant (F(1, 390) = 29.43, P < .001) for pain.Black patients experienced significantly higher pain scores compared to White patients at pretherapy (Mean Difference; MD = 3.7, P = .034), midpoint (MD = 5.8, P = .002), and endpoint (MD = 7.8, P < .001). In the adjusted model, Black race and higher BMI were significant predictors of higher pain scores. Black patients experienced significant deterioration in pain over time. FATIGUE: The scores for fatigue increased significantly from baseline for Black patients by endpoint (MD PHYSICAL FUNCTION: Black patients had significantly lower physical function scores compared to White patients at midpoint (MD = 4.0, P = .027). Physical function decreased by endpoint in Black (MD

conclusionSymptom burden significantly increased over the course of chemotherapy for all patients. Scores for pain and physical function were higher overall for Black patients and deteriorated at a greater rate for Black vs. White women over the course of chemotherapy. BMI was a significant predictor of pain, fatigue, and physical function, this assessment holds implications for proactive assessment and mitigation strategies.

Indexed as

Breast NeoplasmsCancer PainAdultAgedBlack or African AmericanFatigueFemaleHumansLongitudinal StudiesMiddle AgedNeoplasm StagingWhitebreast cancerRacial disparitiessymptom burden

Identifiers

PMID40107464
PMCPMC13220342

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.